Special Issue "3D Bioprinted Scaffolds for Tissue Engineering"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 31 December 2023 | Viewed by 3459
Interests: biomaterials; scaffolds; tissue engineering; legal regulatory aspect; biofabrication and 3D bioprinting
Interests: topical dosage forms; drug delivery; transdermal and transmucosal route; micro- and nanoencapsulation; tissue engineering; cosmetics and dermopharmacy
Special Issues, Collections and Topics in MDPI journals
We are pleased to invite you to contribute to this Special Issue, entitled “3D Bioprinted Scaffolds for Tissue Engineering”.
In recent decades, advances in 3D bioprinting have shown promising innovations in the biofabrication of complex structures such as artificial tissues and/or organs that closely mimic the natural features of tissues or organs in their native forms. Three-dimensional bioprinting combines the use of a device called a bioprinter with bioinks which can be formulated from living cells, biomaterials, and biologically active molecules. The main objective of this technology is to create functional constructs that can replace, preserve, or improve damaged tissues or organs. Three-dimensional bioprinting of scaffolds and constructs with biological, mechanical, and structural characteristics similar to native tissue or organ is currently one of the major challenges in this area.
This Special Issue aims to cover different aspects involved in the 3D bioprinting of artificial tissues and organs for biomedical applications and will include articles focused on the use of novel biomaterials for the bioprinting, design, and formulation of bionks, bioprinting and characterization of scaffolds and constructs, as well as the latest advances in research and clinic.
The final goal is to facilitate the knowledge and scientific innovations into 3D biofabrication of scaffolds as artificial tissues and organs in order to be used for biomedical applications.
In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Patricia Gálvez-Martínf
Dr. Beatriz Clares
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tissue engineering